Substituted oxoazaheterocyclyl compounds

1. A compound of formula

or a pharmaceutically acceptable salt thereof, pharmaceutically acceptable prodrug thereof, an N-oxide thereof, a hydrate thereof or a solvate thereof

wherein

G 1 is L 1 -Cy 1 ;

G 2 is L 2 -Cy 2 ;

Cy 1 and Cy 2 are independently selected from optionally substituted heteroaryl, optionally substituted fused arylheterocyclyl, optionally substituted fused arylheterocyclenyl, optionally substituted fused heteroarylcycloalkyl, optionally substituted fused heteroarylcycloalkenyl, optionally substituted fused heteroarylheterocyclyl and optionally substituted fused heteroarylheterocyclenyl;

L 1 is —S(O) 2 —;

L 2 is C (1-4) alkylene;

A is N;

R 1 , R 1a , R 2 , R 2a , R 4 and R 4a are independently selected from hydrogen, carboxy, alkoxycarbonyl, Y 1 Y 2 NCO, optionally substituted alkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted heteroaryl and optionally substituted heteroaralkyl;

R 3 and R 3a taken together form O;

m is 1;

n is 1; and

Y 1 and Y 2 are independently hydrogen, optionally substituted alkyl, optionally substituted aryl, optionally substituted aralkyl or optionally substituted heteroaralkyl, or Y 1 and Y 2 taken together with the N through which Y 1 and Y 2 are linked form a monocyclic heterocyclyl.

2. A compound according to claim 1 wherein Cy 2 contains at least one nitrogen atom.

3. A compound according to claim 1 wherein R 1 , R 1a , R 2 , R 2a , and R 4 are hydrogen, and R 4a is hydrogen or optionally substituted alkyl.

4. A compound according to claim 1 wherein R 1 , R 2 , R 2a , and R 4 are hydrogen; and R 1a and R 4a are independently selected from hydrogen, carboxy, alkoxycarbonyl, Y 1 Y 2 NCO or optionally substituted alkyl.

5. A compound according to claim 1 wherein L 2 is alkylene of one to three carbon atoms.

6. A pharmaceutical composition comprising a pharmaceutically effective amount of a compound according to claim 1 and a pharmaceutically acceptable carrier.

7. A compound according to claim 1 wherein Cy 2 is optionally substituted with one or more groups selected from amino, carbamoyl, acylamino, heteroaryl, heterocyclenyl, heterocyclyl, alkyl, alkyloxycarbonyl, amidino, hydroxy, alkoxy, aryl, isourea, guanidino, acylhydrazino, acyl, cyano, carboxy, sulfamoyl, or halo.

8. A compound according to claim 1 wherein Cy 2 is optionally substituted with one or more groups selected from amino, hydroxy, or halo.

9. A compound according to claim 1 wherein Cy 1 is optionally substituted with one of more groups selected from amino, halo, hydroxyl, aryl, heteroaryl, amidino, alkyl, acylamino, carbamoyl, cyano, alkoxy, nitro, carbamate, sulfamyl.

10. A compound according to claim 1 wherein at least one of R 1 or R 4 is alkoxyalkyl, alkylthioalkyl, alkylsulfinylalkyl, alkylsulfonylalkyl, alkoxycarbonylalkyl, hydroxyalkyl, acylalkyl, acylaminoalkyl or carbamoylalkyl; and the corresponding R 1a or R 4a is hydrogen.

11. A compound according to claim 1 wherein at least one of R 1 or R 4 is lower alkyl, carboxy, alkoxycarbonyl or carbamoyl, and the corresponding R 1a or R 4a is hydrogen.

12. A compound according to claim 1 having the formula IIb

or a pharmaceutically acceptable salt thereof, pharmaceutically acceptable prodrug thereof, an N-oxide thereof, a hydrate thereof or a solvate thereof,

wherein

R 1 , R 1a , R 2 , R 2a , R 4 , R 4a , L 1 and Cy 1 are as defined in claim 1 ; and

R 13 and R 14 are independently hydrogen, lower alkyl, aryl, heteroaryl, amino, acylaminoalkyl, alkoxycarbonylalkyl, carbamoylalkyl or alkoxyalkyl; or R 13 and R 14 together with the carbon atoms through which R 13 and R 14 are linked form a cycloalkyl group, cycloalkenyl group, heterocyclyl group, heterocyclenyl group, aryl group or heteroaryl group.

13. A compound according to claim 1 having the formula IIc

or a pharmaceutically acceptable salt thereof, pharmaceutically acceptable prodrug thereof, an N-oxide thereof, a hydrate thereof or a solvate thereof,

wherein:

Cy 1 is thiaheteroaryl or azaheteroaryl,

L 1 is —S(O) 2 ;

R 1 , R 1a , R 2 , and R 2a are independently hydrogen, alkyl, carboxyl, alkoxycarbonyl, or carbamoyl;

L 2 is methylene; and

Cy 2 is azaheteroaryl, fused azaheteroarylcycloalkyl, fused azaheteroarylcycloalkenyl, fused heteroarylazacycloalkyl or fused heteroarylazacycloalkenyl.

14. A compound according to claim 1 having the formula IId

wherein R 17 and R 18 are independently hydrogen or halogen;

J 1 is S or NH;

J 2 is CH or N; and

R 2 is hydrogen, alkyl, carboxyl, alkoxycarbonyl, or carbamoyl.

15. A compound according to claim 1 selected from the group consisting of

1-(2- Amino-quinoxalin-6-ylmethyl)-4-(6-chloro-benzo[b]thiopbene2sulfonyl)-piperazin-2-one,

4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-1-thieno[2,3-c]pyridin-2-ylmethyl-piperazin-2-one,

4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-1-thieno[3,2-c]pyridin-2-ylmethyl-piperazin-2-one,

1-(2-Amino-quinolin-6-ylmethyl)-4-(6-chloro-thieno[2,3-b]pyridine2sulfonyl)piperazin2one,

4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-1-(1-chloro-isoquinolin-6-ylmethyl)-piperazin-2-one,

1-(7-Amino-thieno[2,3-c]pyridin-2-ylmethyl)-4-(6-chloro-benzo[b]thiophene-2-sulfonyl)-piperazin-2-one,

4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-1-quinolin-6-ylmethyl-piperazin-2-one,

1-(2-Amino-quinoin-7-ylmethyl )-4-(6-chloro-benzo[b]thiophene-2sulfonyl)-piperazin-2-one,

1-(4-Amino-thieno[3,2-c]pyridin-2-ylmethyl)-4-(6-chloro-benzo[b]thiophene-2sulfonyl)-piperazin-2-one,

4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-1-isoquinolin-6-ylmethyl-piperazin-2-one,

1-(2-Amino-quinolin-6-ylmethyl)-4-(6-chloro-benzo[b]thiophene-2-sulfonyl)-piperazin-2-one,

1-(1-Amino-isoquinolin-6-ylmethyl)-4-(6-chloro-benzo[b]thiophene2sulfonyl)-piperazin2one,

1-(1-Amino-isoquinolin-7-ylmethyI)-4-(6-chloro-benzo[b]thiophene2sulfonyl)-piperazin2-one,

1-(4-Amino-thieno[3,2-c]pyridin-2-ylmethyl)-4-(6-chloro-benzo[b]thiophene-2-sulfonyly)-piperazin-2-one,

1-(4-Amino-quinazolin-7-ylmethyl)-4-(6-chloro-thieno[2,3-b]pyridine-2-sulfonyl)piperazin-2-one,

1-(4-Amino-quinazolin-7-ylmethyl)-4-(6-chloro-1H-benzoimidazole-2-sulfonyl)-piperazin-2-one,

(S)-1-(4-Amino-quinazolin-7-ylmethyl)-4-(6-chloro-benzo[b]thiophene-2-sulfonyl)-3-ethyl-piperazin-2-one,

(S)-1-(4-Amino-quinazolin-7-ylmethyl)-4-(6-chloro-benzo[b]thiophene-2-sulfonyl)-3-methyl-piperazin-2-one,

(+/−)-1-(4-Amino-quinazolin-7-ylmethyl)-4-(6-chloro-benzo[b]thiophene-2-sulfonyl)-6-methyl-piperazin-2-one,

4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-1-(5-oxy-1H-pyrrolo[3,2-c]pyridin-2-ylmethyl)-piperazin-2-one,

4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-1-(1-methyl-1H-pyrrolo[3,2-c]pyridin-2-ylmethyl)-piperazin-2-one,

4-(6-Chloro-thieno[2,3-b]pyridine-2-sulfonyl)-1-(1H-pyrrolo[3,2-c]pyridin-2-ylmethyl)-piperazin-2-one,

4-(6- Bromo-benzo[b]thiophene-2-sulfonyl)-1-(1H-pyrrolo[3,2-c]pyridin-2-ylmethyl)-piperazin-2-one,

4-(5′-Chloro-[2,2′]bithiophenyl-5-sulfonyl)-1-(1H-pyrrolo[3,2-c]pyridin-2-ylmethyl)-piperazin-2-one,

2- {2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo-piperazin-1-ylmethyl]-pyrrolo[3,2-c]pyridin-1-yl}-acetamide,

4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-1-[1-(2-hydroxy-ethyl)-1H-pyrrolo[3,2-c]pyridin-2-ylmethyl]-piperazin-2-one,

4-(6-Chloro-1H-benzoimidazole-2-sulfonyl)-1-(1H-pyrrolo[3,2-c]pyridin-2-ylmethyl)-piperazin-2-one,

4-(1H-Benzoimidazolc-2-sulfonyl)-1-(1H-pyrrolo[3,2-c]pyridin-2-ylmethyl)-piperazin-2-one,

4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-1-(1H-pyrrolo[2,3-c]pyridin-2-ylmethyl)-piperazin-2-one,

4-(6-Chloro-thieno[2,3-b]pyridine-2-sulfonyl)-1-(1H-pyrrolo[2,3-c]pyridin-2-ylmethyl)-piperazin-2-one,

4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-6-oxo-1-(1H-pyrrolo[3,2-c]pyridin-2-ylmethyl)-piperazine-2-carboxylic acid amide,

(3S,5S)-1-(4-Amino-quinazolin-7-ylmethyl)-4-(6-chloro-benzo[b]thiophene-2-sulfonyl)-3,5-dimethyl-piperazin-2-one,

1-(4-Amino-quinolin-7-ylmethyl)-4-(6-chloro-benzo[b]thiophene-2-sulfonyl)-piperazin-2-one,

1-(S)-(4-Amino-quinolin-7-ylmethyl )-4-(6-chloro-benzo[b]thiophene-2-sulfonyl)-3-methyl-piperazin-2-one,

1-(4-Amino-quinolin-7-ylmethyl)-4-(6-chloro-benzo[b]thiophene-2-sulfonyl)-6-oxo-piperazine-2-carboxylic acid methylamide,

1-(4-Amino-quinolin-7-ylmethyl)-4-(6-chloro-benzo[b]thiophene-2-sulfonyl)-6-oxo-piperazine-2-carboxylic acid ethylamide,

1-(4-Amino-quinolin-7-ylmethyl)-4-(6-chloro-benzo[b]thiophene-2-sulfonyl)-6-oxo-piperazine-2-carboxylic acid dimethylamide,

1-(4-Amino-quinolin-7-ylmethyl)-4-(6-chloro-benzo[b]thiophene-2-sulfonyly)-6-(morpholine-4-carbonyl) -piperazin-2-one,

(+/−)-1-(4-Amino-quinazolin-7-ylmethyl)-4-(6-chloro-benzo[b]thiophene-2-sulfonyl)-6-oxo-piperazine-2-carboxylic acid amide,

1-(4-Amino-quinolin-7-ylmethyl)-4-(6-chloro-benzo[b]thiophene-2-sulfonyl)-6-oxo-piperazine-2-carboxylic acid methylamide,

1-(4-Amino-quinolin-7-ylmethyl)-4-(6-chloro-benzo[b]thiophene-2-sulfonyl)-6-oxo-piperazine-2-carboxylic acid ethylamide,

1-(4-Amino-quinolin-7-ylmethyl)-4-(6-chloro-benzo[b]thiophene-2-sulfonyl)-6-oxo-piperazine-2-carboxylic acid dimethylamide,

1-(4-Amino-quinolin-7-ylmethyl)-4-(6-chloro-benzo[b]thiophene-2-sulfonyl)-(morpholine-4-carbonyl) -piperazin-2-one, and

1-(3-Amino-1H-indazol-6-ylmethyl)-4-(6-chloro-benzo[b]thiophene-2-sulfonyl)-piperazin-2-one,

or a pharmaceutically acceptable salt thereof, pharmaceutically acceptable prodrug thereof, an N-oxide thereof, a hydrate thereof or a solvate thereof.